Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone.
Piller LB, Davis BR, Cutler JA, Cushman WC, Wright JT Jr, Williamson JD, Leenen FH, Einhorn PT, Randall OS, Golden JS, Haywood LJ; The ALLHAT Collaborative Research Group. Piller LB, et al. Among authors: einhorn pt. Curr Control Trials Cardiovasc Med. 2002 Nov 14;3(1):10. doi: 10.1186/1468-6708-3-10. Curr Control Trials Cardiovasc Med. 2002. PMID: 12459039 Free PMC article.
Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Davis BR, Kostis JB, Simpson LM, Black HR, Cushman WC, Einhorn PT, Farber MA, Ford CE, Levy D, Massie BM, Nawaz S; ALLHAT Collaborative Research Group. Davis BR, et al. Among authors: einhorn pt. Circulation. 2008 Nov 25;118(22):2259-67. doi: 10.1161/CIRCULATIONAHA.107.762229. Epub 2008 Nov 10. Circulation. 2008. PMID: 19001024 Free PMC article. Clinical Trial.
ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.
Wright JT Jr, Probstfield JL, Cushman WC, Pressel SL, Cutler JA, Davis BR, Einhorn PT, Rahman M, Whelton PK, Ford CE, Haywood LJ, Margolis KL, Oparil S, Black HR, Alderman MH; ALLHAT Collaborative Research Group. Wright JT Jr, et al. Among authors: einhorn pt. Arch Intern Med. 2009 May 11;169(9):832-42. doi: 10.1001/archinternmed.2009.60. Arch Intern Med. 2009. PMID: 19433694 Free PMC article. Clinical Trial.
Getting clinical trial results into practice: design, implementation, and process evaluation of the ALLHAT Dissemination Project.
Bartholomew LK, Cushman WC, Cutler JA, Davis BR, Dawson G, Einhorn PT, Graumlich JF, Piller LB, Pressel S, Roccella EJ, Simpson L, Whelton PK, Williard A, Allhat Collaborative Research Group. Bartholomew LK, et al. Among authors: einhorn pt. Clin Trials. 2009 Aug;6(4):329-43. doi: 10.1177/1740774509338234. Epub 2009 Jul 8. Clin Trials. 2009. PMID: 19587068 Free PMC article.
Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
Piller LB, Baraniuk S, Simpson LM, Cushman WC, Massie BM, Einhorn PT, Oparil S, Ford CE, Graumlich JF, Dart RA, Parish DC, Retta TM, Cuyjet AB, Jafri SZ, Furberg CD, Saklayen MG, Thadani U, Probstfield JL, Davis BR; ALLHAT Collaborative Research Group. Piller LB, et al. Among authors: einhorn pt. Circulation. 2011 Oct 25;124(17):1811-8. doi: 10.1161/CIRCULATIONAHA.110.012575. Epub 2011 Oct 3. Circulation. 2011. PMID: 21969009 Free PMC article. Clinical Trial.
Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT]).
Alderman MH, Davis BR, Piller LB, Ford CE, Baraniuk MS, Pressel SL, Assadi MA, Einhorn PT, Haywood LJ, Ilamathi E, Oparil S, Retta TM; ALLHAT Collaborative Research Group. Alderman MH, et al. Among authors: einhorn pt. Am J Cardiol. 2016 Jan 1;117(1):105-15. doi: 10.1016/j.amjcard.2015.10.012. Epub 2015 Oct 19. Am J Cardiol. 2016. PMID: 26589819 Free PMC article. Clinical Trial.
Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Ernst ME, Davis BR, Soliman EZ, Prineas RJ, Okin PM, Ghosh A, Cushman WC, Einhorn PT, Oparil S, Grimm RH Jr; ALLHAT Collaborative Research Group. Ernst ME, et al. Among authors: einhorn pt. J Am Soc Hypertens. 2016 Dec;10(12):930-938.e9. doi: 10.1016/j.jash.2016.10.010. Epub 2016 Nov 9. J Am Soc Hypertens. 2016. PMID: 27938852 Free PMC article. Clinical Trial.
Risk Factors Influencing Outcomes of Atrial Fibrillation in ALLHAT.
Haywood LJ, Davis BR, Piller LB, Simpson LM, Ghosh A, Einhorn PT, Ford CE, Probstfield JL, Soliman EZ, Wright JT Jr; ALLHAT Collaborative Research Group. Haywood LJ, et al. Among authors: einhorn pt. J Natl Med Assoc. 2018 Aug;110(4):343-351. doi: 10.1016/j.jnma.2017.07.003. Epub 2017 Jul 24. J Natl Med Assoc. 2018. PMID: 30126559 Free PMC article. Clinical Trial.
Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Margolis KL, Piller LB, Ford CE, Henriquez MA, Cushman WC, Einhorn PT, Colon PJ Sr, Vidt DG, Christian R, Wong ND, Wright JT Jr, Goff DC Jr; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Margolis KL, et al. Among authors: einhorn pt. Hypertension. 2007 Nov;50(5):854-61. doi: 10.1161/HYPERTENSIONAHA.107.092650. Epub 2007 Sep 10. Hypertension. 2007. PMID: 17846352 Clinical Trial.
44 results